208 related articles for article (PubMed ID: 33094561)
21. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
22. ZFPM2-AS1 promotes the proliferation, migration, and invasion of human non-small cell lung cancer cells involving the JAK-STAT and AKT pathways.
Wang X; Tang J; Zhao J; Lou B; Li L
PeerJ; 2020; 8():e10225. PubMed ID: 33173620
[TBL] [Abstract][Full Text] [Related]
23. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
24. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
25. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
[TBL] [Abstract][Full Text] [Related]
26. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
27. IGF2BP3 Expression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Wakita A; Motoyama S; Sato Y; Nagaki Y; Fujita H; Terata K; Imai K; Maeda E; Minamiya Y
J Surg Res; 2021 Mar; 259():137-144. PubMed ID: 33279839
[TBL] [Abstract][Full Text] [Related]
28. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
Li M; Zheng R; Yuan FL
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11462. PubMed ID: 33275202
[TBL] [Abstract][Full Text] [Related]
29. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein.
Müeller-Pillasch F; Lacher U; Wallrapp C; Micha A; Zimmerhackl F; Hameister H; Varga G; Friess H; Büchler M; Beger HG; Vila MR; Adler G; Gress TM
Oncogene; 1997 Jun; 14(22):2729-33. PubMed ID: 9178771
[TBL] [Abstract][Full Text] [Related]
30. Bladder Cancer: A Review.
Lenis AT; Lec PM; Chamie K; Mshs MD
JAMA; 2020 Nov; 324(19):1980-1991. PubMed ID: 33201207
[TBL] [Abstract][Full Text] [Related]
31. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.
Pan Z; Zhao R; Li B; Qi Y; Qiu W; Guo Q; Zhang S; Zhao S; Xu H; Li M; Gao Z; Fan Y; Xu J; Wang H; Wang S; Qiu J; Wang Q; Guo X; Deng L; Zhang P; Xue H; Li G
Mol Cancer; 2022 Jan; 21(1):16. PubMed ID: 35031058
[TBL] [Abstract][Full Text] [Related]
32. Binding of RNA m6A by IGF2BP3 triggers chemoresistance of HCT8 cells via upregulation of ABCB1.
Yang Z; Zhao F; Gu X; Feng L; Xu M; Li T; Liu X; Zhang X
Am J Cancer Res; 2021; 11(4):1428-1445. PubMed ID: 33948366
[TBL] [Abstract][Full Text] [Related]
33. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex.
Ma Q; Yang F; Huang B; Pan X; Li W; Yu T; Wang X; Ran L; Qian K; Li H; Li H; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Xiao B
J Exp Clin Cancer Res; 2022 Aug; 41(1):251. PubMed ID: 35986300
[TBL] [Abstract][Full Text] [Related]
34. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
[TBL] [Abstract][Full Text] [Related]
35. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Du M; Peng Y; Li Y; Sun W; Zhu H; Wu J; Zong D; Wu L; He X
Cell Death Discov; 2022 Feb; 8(1):53. PubMed ID: 35136045
[TBL] [Abstract][Full Text] [Related]
36. IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma.
Xu Y; Guo Z; Peng H; Guo L; Wang P
J Cell Mol Med; 2022 Jan; 26(2):410-421. PubMed ID: 34894048
[TBL] [Abstract][Full Text] [Related]
37. linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA.
Huang GW; Chen QQ; Ma CC; Xie LH; Gu J
Int J Biochem Cell Biol; 2021 Jul; 136():106015. PubMed ID: 34022433
[TBL] [Abstract][Full Text] [Related]
38. USP11 facilitates colorectal cancer proliferation and metastasis by regulating IGF2BP3 stability.
Huang YY; Zhang CM; Dai YB; Lin JG; Lin N; Huang ZX; Xu TW
Am J Transl Res; 2021; 13(2):480-496. PubMed ID: 33594305
[TBL] [Abstract][Full Text] [Related]
39. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.
Li B; Zhu L; Lu C; Wang C; Wang H; Jin H; Ma X; Cheng Z; Yu C; Wang S; Zuo Q; Zhou Y; Wang J; Yang C; Lv Y; Jiang L; Qin W
Nat Commun; 2021 Jan; 12(1):295. PubMed ID: 33436560
[TBL] [Abstract][Full Text] [Related]
40.
Mäkinen A; Nikkilä A; Haapaniemi T; Oksa L; Mehtonen J; Vänskä M; Heinäniemi M; Paavonen T; Lohi O
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
